Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2012 December;58(4) > Minerva Gastroenterologica e Dietologica 2012 December;58(4):365-75

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GASTROENTEROLOGICA E DIETOLOGICA

A Journal on Gastroenterology, Nutrition and Dietetics


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

  PANCREATIC DISEASES: A CLOSER LOOK


Minerva Gastroenterologica e Dietologica 2012 December;58(4):365-75

Copyright © 2012 EDIZIONI MINERVA MEDICA

language: English

Pharmacological therapy for acute pancreatitis: where are we now? where are we going?

Easler J. J., Mounzer R., Papachristou G. I.

Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medi cal Center, Pittsburgh, PA, USA


PDF  


Acute pancreatitis is a disease of variable severity that can lead to significant morbidity and mortality. Current management has remained limited to supportive measures and the treatment of complications. A myriad of pharmacologic therapies targeting various aspects of the underlying pathophysiology have been evaluated over the past few decades. These have included antisecretory agents, protease inhibitors, antioxidants, immunomodulators, non-steroidal anti-inflammatory medications, and prophylactic antibiotics. A few of these therapies have demonstrated promise in significantly altering the progression of this disease. Further studies are needed to clearly elucidate these benefits in patients at risk for poor outcomes

top of page

Publication History

Cite this article as

Corresponding author e-mail

papachri@pitt.edu